Scinovex
articleTop 1% cited

A COMPARISON OF TACROLIMUS (FK506) AND CYCLOSPORINE FOR IMMUNOSUPPRESSION AFTER CADAVERIC RENAL TRANSPLANTATION1

Transplantation · 1997 · Vol. 63(7) · pp. 977–983

Abstract

Tacrolimus is more effective than cyclosporine in preventing acute rejection in cadaveric renal allograft recipients, and significantly reduces the use of antilymphocyte antibody preparations. Tacrolimus was associated with a higher incidence of neurologic events, which were rarely treatment limiting, and with posttransplant diabetes mellitus, which was reversible in some patients.

Renal Transplantation Outcomes and TreatmentsOrgan Transplantation Techniques and OutcomesNeurological Complications and SyndromesTacrolimusMedicineImmunosuppressionTransplantationCiclosporinGastroenterologyIncidence (geometry)KidneyKidney transplantationUrology

MeSH terms

Acute DiseaseAdultAntilymphocyte SerumCadaverCause of DeathClinical ProtocolsCreatinineDiabetes MellitusFemaleGraft RejectionHumansImmunosuppressive AgentsInsulinMaleRegression Analysis
Citations
1,136
FWCI
45.92
field-weighted impact
References
19
Percentile
100%
vs. same field & year
Citations per year
Citation Network

How this paper connects to the literature. Drag to explore, click any node to open that paper.